Lupus anticoagulant, disease activity and low complement in the first trimester are predictive of pregnancy loss

Lupus Science and Medicine

Volumn 2, Issue 1, 2015, Pages

  Mankee, Anil ^a   Petri, Michelle ^b   Magder, Laurence S ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Antiphospholipid Antibodies; Outcomes research; Systemic Lupus Erythematosus

Indexed keywords

CARDIOLIPIN ANTIBODY; COMPLEMENT; IMMUNOGLOBULIN G ANTIBODY; LUPUS ANTICOAGULANT; PREDNISONE; SNAKE VENOM;

ADULT; AFRICAN AMERICAN; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CAUCASIAN; COHORT ANALYSIS; COMPARATIVE STUDY; COMPLEMENT BLOOD LEVEL; DABOIA RUSSELLII; DISEASE ACTIVITY; FEMALE; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL HISTORY; PREDICTIVE VALUE; PREGNANCY OUTCOME; PRIORITY JOURNAL; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THIRD TRIMESTER PREGNANCY; THROMBOSIS;

EID: 84988587411     PISSN: None     EISSN: 20538790     Source Type: Journal    
DOI: 10.1136/lupus-2015-000095     Document Type: Article

References (24)

1. Clark C, Spitzer K, Laskin C. Decrease in pregnancy loss rate in patients with systemic lupus erythematosus over a 40 year period. J Rheumatol 2005;32:1709-12.
2. Clowse ME, Magder LS, Petri M. The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus. J Rheumatol 2011;38:1012-16.
3. Lockshin MD, Kim M, Laskin CA, et al. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum 2012;64:2311-18.
4. Yuen SY, Krizova A, Ouimet JM, et al. Pregnancy outcome in systemic lupus erythematosus is improving: Results from a case control study and literature review. Open Rheumatol J 2008;2:89-98.
5. Mecacci F, Bianchi B, Pieralli A, et al. Pregnancy outcome in systemic lupus erythematosus complicated by antiphospholipid antibodies. Rheumatology (Oxford) 2009;48:246-9.
6. Brucato A, Doria A, Frassi M, et al. Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. Lupus 2002;11:716-21.
7. Wong CH, Chen TL, Lee CS, et al. Outcome of pregnancy in patients with systemic lupus erythematosus. Taiwan J Obstet Gynecol 2006;45:120-3.
8. Andrade R, Sanchez ML, Alarcon GS, et al. Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LVI). Clin Exp Rheumatol 2008;26:268-74.
9. Clowse ME, Magder LS, Witter F, et al. Early risk factors for pregnancy loss in lupus. Obstet Gynecol 2006;107:293-9.
10. Clowse ME, Magder LS, Witter F, et al. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 2005;52:514-21.
11. Lathi RB, Gray Hazard FK, Heerema-McKenney A, et al. First trimester miscarriage evaluation. Semin Reprod Med 2011;29:463-9.
12. Suzumori N, Sugiura-Ogasawara M. Genetic factors as a cause of miscarriage. Curr Med Chem 2010;17:3431-7.
13. Lebedev I. Mosaic aneuploidy in early fetal losses. Cytogenet Genome Res 2011;133:169-83.
14. Porter TF, Scott JR. Evidence-based care of recurrent miscarriage. Best Pract Res Clin Obstet Gynaecol 2005;19:85-101.
15. Lima F, Buchanan N, Khamashta MA, et al. Obstetric outcomes in systemic lupus erythematosus. Semin Arthritis Rheum 1995;25:184-92.
16. Derksen RH, Bruinse HW, de Groot PG, et al. Pregnancy in systemic lupus erythematosus: a prospective study. Lupus 1994;3:149-55.
17. Moroni G, Quaglini S, Banfi G, et al. Pregnancy in lupus nephritis. Am J Kidney Dis 2002;40:713-20.
18. Petri M, Genovese M, Engle E, et al. Definition, incidence and clinical description of flare in systemic lupus erythematosus. Arthritis Rheum 1991;34:937-44.
19. Petri M, Nelson L, Weimer F, et al. The automated modified Russell viper venom time test for the lupus anticoagulant. J Rheumatol 1991;18:1823-5.
20. Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 2009;7: 1737-40.
21. Chakravarty EF, Colón I, Langen ES, et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obs Gynecol 2005;192:1897-904.
22. Ramos-Casals M, Campoamor MT, Chamorro A, et al. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients. Lupus 2004;13:777-83.
23. Cortés-Hernández J, Ordi-Ros J, Paredes F, et al. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford) 2002;41:643-50.
24. Steiman AJ, Gladman DD, Ibañez D, et al. Outcomes in patients with systemic lupus erythematosus with and without a prolonged serologically active clinically quiescent period. Arthritis Care Res (Hoboken) 2012;64:511-18.